{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:12:22Z","timestamp":1762272742470},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Children affected by Coronavirus disease 2019 (COVID-19) showed various manifestations. Some of them were severe cases presenting with multi-system inflammatory syndrome (MIS-C) causing multiple organ dysfunction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of a 12-year-old girl with recent COVID-19 infection who presented with persistent fever, abdominal pain and other symptoms that meet the definition of MIS-C. She had lymphopenia and a high level of inflammatory markers. She was admitted to pediatric intensive care unit since she rapidly developed refractory catecholamine-resistant shock with multiple organ failure. Echocardiography showed a small pericardial effusion with a normal ejection fraction (Ejection Fraction\u2009=\u200960%) and no valvular or coronary lesions. The child showed no signs of improvement even after receiving intravenous immunoglobulin, fresh frozen plasma, high doses of Vasopressors and corticosteroid. His outcome was fatal.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Pediatric patients affected by the new COVID-19 related syndrome may show severe life-threatening conditions similar to Kawasaki disease shock syndrome. Hypotension in these patients results from heart failure and the decreased cardiac output. We report a new severe clinical feature of SARS-CoV-2 infection in children in whom hypotension was the result of refractory vasoplegia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-021-01070-z","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T09:04:59Z","timestamp":1622624699000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A fatal toxic shock-like syndrome post COVID-19 infection in a child"],"prefix":"10.1186","volume":"47","author":[{"given":"Houda","family":"Ajmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wissem","family":"Besghaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafa","family":"Kallala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelhalim","family":"Trabelsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saoussan","family":"Abroug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"key":"1070_CR1","first-page":"S1526","volume":"11","author":"T Radia","year":"2020","unstructured":"Radia T, Williams N, Agrawal P, et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatr Respir Rev. 2020;11:S1526\u20130542.","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"1070_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11596-020-2172-6","volume":"40","author":"F Zheng","year":"2020","unstructured":"Zheng F, Liao C, Fan Q, Chen HB, Zhao XG, Xie ZG, et al. Clinical characteristics of children with coronavirus disease 2019 in Hubei, China. Curr Med Sci. 2020;40(2):275\u201380. https:\/\/doi.org\/10.1007\/s11596-020-2172-6.","journal-title":"Curr Med Sci"},{"issue":"7","key":"1070_CR3","first-page":"69","volume":"7","author":"NA Nakra","year":"2020","unstructured":"Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children (Basel). 2020;7(7):69.","journal-title":"Children (Basel)"},{"issue":"3","key":"1070_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2020.10369","volume":"324","author":"E Whittaker","year":"2020","unstructured":"Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259\u201369. https:\/\/doi.org\/10.1001\/jama.2020.10369.","journal-title":"JAMA."},{"issue":"11","key":"1070_CR5","doi-asserted-by":"publisher","first-page":"2492.e5","DOI":"10.1016\/j.ajem.2020.05.117","volume":"38","author":"AG Greene","year":"2020","unstructured":"Greene AG, Saleh M, Roseman E, Sinert R. Toxic shock-like syndrome and COVID-19: Multisystem inflammatory syndrome in children (MIS-C). Am J Emerg Med. 2020;38(11):2492.e5\u20136.","journal-title":"Am J Emerg Med"},{"issue":"9","key":"1070_CR6","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00134-015-3861-7","volume":"41","author":"JP Burnham","year":"2015","unstructured":"Burnham JP, Kollef MH. Understanding toxic shock syndrome. Intensive Care Med. 2015;41(9):1707\u201310. https:\/\/doi.org\/10.1007\/s00134-015-3861-7.","journal-title":"Intensive Care Med"},{"key":"1070_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.prrv.2020.07.003","volume":"35","author":"T Tanner","year":"2020","unstructured":"Tanner T, Wahezi DM. Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19. Paediatr Respir Rev. 2020;35:81\u20137. https:\/\/doi.org\/10.1016\/j.prrv.2020.07.003.","journal-title":"Paediatr Respir Rev"},{"issue":"10","key":"1070_CR8","doi-asserted-by":"publisher","first-page":"2246.e3","DOI":"10.1016\/j.ajem.2020.05.058","volume":"38","author":"T Waltuch","year":"2020","unstructured":"Waltuch T, Gill P, Zinns LE, et al. Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department. Am J Emerg Med. 2020;38(10):2246.e3\u20136.","journal-title":"Am J Emerg Med"},{"key":"1070_CR9","doi-asserted-by":"publisher","first-page":"117900","DOI":"10.1016\/j.lfs.2020.117900","volume":"256","author":"F Yazdanpanah","year":"2020","unstructured":"Yazdanpanah F, Hamblin MR, Rezaei N. The immune system and COVID-19: friend or foe? Life Sci. 2020;256:117900. https:\/\/doi.org\/10.1016\/j.lfs.2020.117900.","journal-title":"Life Sci"},{"issue":"6","key":"1070_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jemermed.2017.12.048","volume":"54","author":"M Gottlieb","year":"2018","unstructured":"Gottlieb M, Long B, Koyfman A. The evaluation and Management of Toxic Shock Syndrome in the emergency department: a review of the literature. J Emerg Med. 2018;54(6):807\u201314. https:\/\/doi.org\/10.1016\/j.jemermed.2017.12.048.","journal-title":"J Emerg Med"},{"issue":"8","key":"1070_CR11","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/archdischild-2015-310121","volume":"101","author":"KYH Chen","year":"2016","unstructured":"Chen KYH, Cheung M, Burgner DP, Curtis N. Toxic shock syndrome in Australian children. Arch Dis Child. 2016;101(8):736\u201340. https:\/\/doi.org\/10.1136\/archdischild-2015-310121.","journal-title":"Arch Dis Child"},{"issue":"6","key":"1070_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/cid\/ciu449","volume":"59","author":"A Linner","year":"2014","unstructured":"Linner A, Darenberg J, Sjolin J, Henriques-Normark B, Norrby-Teglund A. Clinical efficacy of Polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis. 2014;59(6):851\u20137. https:\/\/doi.org\/10.1093\/cid\/ciu449.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1070_CR13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/jama.2021.0694","volume":"325","author":"N Ouldali","year":"2021","unstructured":"Ouldali N, Toubiana J, Antona D, Javouhey E, Madhi F, Lorrot M, et al. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA. 2021;325(9):855\u201364. https:\/\/doi.org\/10.1001\/jama.2021.0694.","journal-title":"JAMA"},{"key":"1070_CR14","doi-asserted-by":"publisher","first-page":"m2094","DOI":"10.1136\/bmj.m2094","volume":"369","author":"J Toubiana","year":"2020","unstructured":"Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094.","journal-title":"BMJ"},{"issue":"11","key":"1070_CR15","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1016\/S1473-3099(20)30651-4","volume":"20","author":"L Jiang","year":"2020","unstructured":"Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20(11):e276\u201388. https:\/\/doi.org\/10.1016\/S1473-3099(20)30651-4.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1070_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. New York state and Centers for Disease Control and Prevention multisystem inflammatory syndrome in children investigation team. Multisystem inflammatory syndrome in children in New York state. N Engl J Med. 2020;383(4):347\u201358. https:\/\/doi.org\/10.1056\/NEJMoa2021756.","journal-title":"N Engl J Med"},{"issue":"11","key":"1070_CR17","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/art.41454","volume":"72","author":"LA Henderson","year":"2020","unstructured":"Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS\u2013CoV-2 and Hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol. 2020;72(11):1791\u2013805. https:\/\/doi.org\/10.1002\/art.41454.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"1070_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S2352-4642(20)30304-7","volume":"5","author":"R Harwood","year":"2021","unstructured":"Harwood R, Allin B, Jones CE, Whittaker E, Ramnarayan P, Ramanan AV, et al. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process. Lancet Child Adolesc Health. 2021;5(2):133\u201341. https:\/\/doi.org\/10.1016\/S2352-4642(20)30304-7.","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"1070_CR19","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1097\/PCC.0000000000002598","volume":"22","author":"B Jonat","year":"2021","unstructured":"Jonat B, Gorelik M, Boneparth A, Geneslaw AS, Zachariah P, Shah A, et al. Multisystem inflammatory syndrome in children associated with coronavirus disease 2019 in a Children\u2019s Hospital in new York City: PatientCharacteristics and an institutional protocol for evaluation, management, and follow-up. Pediatr Crit Care Med. 2021;22(3):e178\u201391. https:\/\/doi.org\/10.1097\/PCC.0000000000002598.","journal-title":"Pediatr Crit Care Med"},{"issue":"7","key":"1070_CR20","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/jmv.25801","volume":"92","author":"P Luo","year":"2020","unstructured":"Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID-19: a single center experience. J Med Virol. 2020;92(7):814\u20138. https:\/\/doi.org\/10.1002\/jmv.25801.","journal-title":"J Med Virol"},{"issue":"2","key":"1070_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.34172\/aim.2021.22","volume":"24","author":"M Farrokhpour","year":"2021","unstructured":"Farrokhpour M, Rezaie N, Moradi N, Ghaffari Rad F, Izadi S, Azimi M, et al. Infliximab and intravenous Gammaglobulin in hospitalized severe COVID-19 patients in intensive care unit. Arch Iran Med. 2021;24(2):139\u201343. https:\/\/doi.org\/10.34172\/aim.2021.22.","journal-title":"Arch Iran Med"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01070-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-021-01070-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01070-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T09:12:55Z","timestamp":1622625175000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-021-01070-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1070"],"URL":"https:\/\/doi.org\/10.1186\/s13052-021-01070-z","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,2]]},"assertion":[{"value":"19 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s parent for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}